TNFRSF8 and lung cancer: This targeted approach allows for more precise and personalized treatment strategies for managing CD30-positive lymphomas.303 Therefore, Kang et al. used [89Zr]Zr-DFO-BV for noninvasive imaging of CD30 expression in different lung cancer models.